| 1 |
2025 |
Chao Zhang, Neha, Jiaqi Zhang, Prashant Dhaha, Xiaodie Li, Sarad Kumar Mishra, Joshua Fleishman, Suhel Parvez, Saurabh Kumar Jha, Min Huang. Aging and senescence: Key players in brain tumor progression and drug resistance, Drug Resistance Updates. 2025; 81: 101228101228.
https://doi.org/10.1016/j.drup.2025.101228 |
| 2 |
2025 |
Nermin Ezat Elbakry Abdelmahdy, Essra Tajelsir Abd Alnour Suliman , Fatima Mahmoud Osman Mohmed, Nazik Siddig Ali Elamin, Belgees Altigani Hamza Yousif, Nazik Abbas Mohammed Ahmmed. Diagnostic Performance of Neural Network-Based Artificial Intelligence in the Detection and Classification of Pediatric Astrocytoma: A Systematic Review, Cureus. 2025;
https://doi.org/10.7759/cureus.83543 |
| 3 |
2024 |
Dona A. Johns, Richard J. Williams, Craig M. Smith, Pavani P. Nadaminti, Rasika M. Samarasinghe. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma, Clinical and Translational Medicine. 2024; 14: e1560.
https://doi.org/10.1002/ctm2.1560 |
| 4 |
2025 |
Daniel A. Brenner, Nicholas B. Dadario, Ashraf Zaman, Daniel J. Valdivia, Madhavi Pandya, Jacky Yeung, Michael Sughrue, Charlie Teo. Surgical outcomes in high-grade adult type diffuse gliomas (ATDG) with a previous diagnosis of anaplastic astrocytoma without adjuvant therapy, Clinical Neurology and Neurosurgery. 2025; 253: 108879108879.
https://doi.org/10.1016/j.clineuro.2025.108879 |
| 5 |
2024 |
Ana Stepanović, Nataša Terzić Jovanović, Aleksandra Korać, Mario Zlatović, Igor Nikolić, Igor Opsenica, Milica Pešić. Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma, Biomedicine & Pharmacotherapy. 2024; 174: 116496116496.
https://doi.org/10.1016/j.biopha.2024.116496 |
| 6 |
2024 |
Girish M. Fatterpekar, Pia C. Sundgren. 2024; 41.
https://doi.org/10.1007/978-3-031-50675-8_4 |
